| Jason Peter Ortolano, PT, DPT | |
|
340 Great Rd, Acton, MA 01720-4020 | |
| (978) 287-6170 | |
| (978) 287-1476 |
| Full Name | Jason Peter Ortolano |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 340 Great Rd, Acton, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992126114 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 035771 (New York) | Secondary |
| 225100000X | Physical Therapist | PTL21781 (Massachusetts) | Primary |
| Entity Name | Performance Rehabilitation Of Western New England Llc |
|---|---|
| Entity Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Entity Identifiers | NPI Number: 1710919063 PECOS PAC ID: 7911979950 Enrollment ID: O20040810000712 |
News Archive
Women with recurrent ovarian cancer can be helped by an experimental therapy using a drug already touted for its ability to fight other cancers, a finding that provides hope for improved treatment of this deadly disease.
"Internet-based news and Twitter feeds were faster than traditional sources at detecting the onset and progression of the cholera epidemic in post-earthquake Haiti ..., according to a new study published in the January issue of the American Journal of Tropical Medicine and Hygiene (AJTMH)," an AJTMH press release states.
A research team at Emory University is embarking on a multipronged study of 3q29 deletion syndrome, a genetic mutation associated with a 40-fold increased risk for schizophrenia and a range of other neuropsychiatric conditions including mild to moderate intellectual disability, autism and anxiety.
Researchers at the University of Rochester Medical Center has announced that they have launched a study to determine whether an experimental drug, rimonabant, can slow atherosclerosis, the fatty build-up in arteries that creates heart attack risk.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jason Peter Ortolano, PT, DPT 790 Remington Blvd, Bolingbrook, IL 60440-4909 Ph: (866) 370-8206 | Jason Peter Ortolano, PT, DPT 340 Great Rd, Acton, MA 01720-4020 Ph: (978) 287-6170 |
News Archive
Women with recurrent ovarian cancer can be helped by an experimental therapy using a drug already touted for its ability to fight other cancers, a finding that provides hope for improved treatment of this deadly disease.
"Internet-based news and Twitter feeds were faster than traditional sources at detecting the onset and progression of the cholera epidemic in post-earthquake Haiti ..., according to a new study published in the January issue of the American Journal of Tropical Medicine and Hygiene (AJTMH)," an AJTMH press release states.
A research team at Emory University is embarking on a multipronged study of 3q29 deletion syndrome, a genetic mutation associated with a 40-fold increased risk for schizophrenia and a range of other neuropsychiatric conditions including mild to moderate intellectual disability, autism and anxiety.
Researchers at the University of Rochester Medical Center has announced that they have launched a study to determine whether an experimental drug, rimonabant, can slow atherosclerosis, the fatty build-up in arteries that creates heart attack risk.
› Verified 6 days ago